Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Treatment recommendations for generalized convulsive status epilepticus emerge from VA study

Oct. 14, 1998

Roche presents series of OFQ (ORL1) receptor agonists/antagonists

Oct. 14, 1998

Stroke patients benefit from treatment with anti-ICAM-1 MAb

Oct. 14, 1998

New heteroarylsulfonamide derivatives from Knoll with broad clinical application

Oct. 14, 1998

Pharmos successfully completes phase II head trauma study

Oct. 13, 1998

5-HT2C agonist shows potential for treating OCD and depression

Oct. 13, 1998

Lundbeck develops new antipsychotic agents acting on D1 receptors

Oct. 13, 1998

Novel central 5-HT1A receptor agonists characterized in binding and animal studies

Oct. 13, 1998

Celgene initiates pivotal trials with d-MPH

Oct. 9, 1998

Creative BioMolecules receives NIH grant for Parkinson's disease research

Oct. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D
BioWorld Science
Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.